1. FDA approves Sarepta’s DMD drug that it had previously rejected — Biogen chalks up another failure — The House passes the Lower Drug Costs Now Act, but it’s unlikely to become law — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Critical Therapooptics!

Discussion in 'Critical Therapeutics' started by Anonymous, Apr 18, 2011 at 5:51 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    It's a better, reflective name!